Samsara Therapeutics

autophagy activation, phenotypic screening, iPSCs

clearingsmall molecule

samsaratherapeutics.com·United States·Founded 2019·Series A·$25M total funding

Plate C · C-7H02

Люди

Nils ReggeКлючевое лицо

co founder · site_team_page · 0.75

cso · site_team_page · 0.75

employee · site_team_page · 0.75

employee · site_team_page · 0.75

employee · site_team_page · 0.75

employee · site_team_page · 0.75

Загрузка раздела...

0-100 chain-logic scale · 15 dimensions · scored on public evidence